103 related articles for article (PubMed ID: 21044747)
1. Florid lobular intraepithelial neoplasia with signet ring cells, central necrosis and calcifications: a clinicopathological and immunohistochemical analysis of ten cases associated with invasive lobular carcinoma.
Alvarado-Cabrero I; Picón Coronel G; Valencia Cedillo R; Canedo N; Tavassoli FA
Arch Med Res; 2010 Aug; 41(6):436-41. PubMed ID: 21044747
[TBL] [Abstract][Full Text] [Related]
2. Lobular intraepithelial neoplasia [lobular carcinoma in situ] with comedo-type necrosis: A clinicopathologic study of 18 cases.
Fadare O; Dadmanesh F; Alvarado-Cabrero I; Snyder R; Stephen Mitchell J; Tot T; Wang SA; Ghofrani M; Eusebi V; Martel M; Tavassoli FA
Am J Surg Pathol; 2006 Nov; 30(11):1445-53. PubMed ID: 17063087
[TBL] [Abstract][Full Text] [Related]
3. Pleomorphic lobular carcinoma in situ of the breast composed almost entirely of signet ring cells.
Fadare O
Pathol Int; 2006 Nov; 56(11):683-7. PubMed ID: 17040292
[TBL] [Abstract][Full Text] [Related]
4. Lobular carcinoma, not only a classic.
Brogi E; Murray MP; Corben AD
Breast J; 2010; 16 Suppl 1():S10-4. PubMed ID: 21050299
[TBL] [Abstract][Full Text] [Related]
5. Positioning of necrotic lobular intraepithelial neoplasias (LIN, grade 3) within the sequence of breast carcinoma progression.
Boldt V; Stacher E; Halbwedl I; Popper H; Hultschig C; Moinfar F; Ullmann R; Tavassoli FA
Genes Chromosomes Cancer; 2010 May; 49(5):463-70. PubMed ID: 20155841
[TBL] [Abstract][Full Text] [Related]
6. Differential expression of E-cadherin in lobular and ductal neoplasms of the breast and its biologic and diagnostic implications.
Acs G; Lawton TJ; Rebbeck TR; LiVolsi VA; Zhang PJ
Am J Clin Pathol; 2001 Jan; 115(1):85-98. PubMed ID: 11190811
[TBL] [Abstract][Full Text] [Related]
7. Simultaneous loss of E-cadherin and catenins in invasive lobular breast cancer and lobular carcinoma in situ.
De Leeuw WJ; Berx G; Vos CB; Peterse JL; Van de Vijver MJ; Litvinov S; Van Roy F; Cornelisse CJ; Cleton-Jansen AM
J Pathol; 1997 Dec; 183(4):404-11. PubMed ID: 9496256
[TBL] [Abstract][Full Text] [Related]
8. In situ lobular neoplasia of the breast with marked myoepithelial proliferation.
Shousha S
Histopathology; 2011 Jun; 58(7):1081-5. PubMed ID: 21707709
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathologic implications of E-cadherin reactivity in patients with lobular carcinoma in situ of the breast.
Reis-Filho JS; Cancela Paredes J; Milanezi F; Schmitt FC
Cancer; 2002 Apr; 94(7):2114-5; author reply 2115-6. PubMed ID: 11932917
[No Abstract] [Full Text] [Related]
10. Signet ring variant of lobular carcinoma of the breast: a clinicopathologic and immunohistochemical study.
Raju U; Ma CK; Shaw A
Mod Pathol; 1993 Sep; 6(5):516-20. PubMed ID: 8248106
[TBL] [Abstract][Full Text] [Related]
11. Lobular carcinoma in situ diagnosed by core needle biopsy: when should it be excised?
Middleton LP; Grant S; Stephens T; Stelling CB; Sneige N; Sahin AA
Mod Pathol; 2003 Feb; 16(2):120-9. PubMed ID: 12591964
[TBL] [Abstract][Full Text] [Related]
12. In-situ lobular/myoepithelial neoplasia of the breast.
Shousha S; Knee G
Histopathology; 2004 Jul; 45(1):93-5. PubMed ID: 15228454
[No Abstract] [Full Text] [Related]
13. E-cadherin expression in pleomorphic lobular carcinoma: an aid to differentiation from ductal carcinoma.
Wahed A; Connelly J; Reese T
Ann Diagn Pathol; 2002 Dec; 6(6):349-51. PubMed ID: 12478484
[TBL] [Abstract][Full Text] [Related]
14. Lobular neoplasia displaying central necrosis: a potential diagnostic pitfall.
Rosa M; Mohammadi A; Masood S
Pathol Res Pract; 2010 Aug; 206(8):544-9. PubMed ID: 20359832
[TBL] [Abstract][Full Text] [Related]
15. Role of E-cadherins in development of lymphatic tumor emboli.
Gupta A; Deshpande CG; Badve S
Cancer; 2003 May; 97(9):2341-7. PubMed ID: 12712492
[TBL] [Abstract][Full Text] [Related]
16. Histiocytoid breast carcinoma: solid variant of invasive lobular carcinoma with decreased expression of both E-cadherin and CD44 epithelial variant.
Fujiwara M; Horiguchi M; Mori S; Yokoyama K; Horiguchi H; Fukazawa M; Fujiwara H; Yano Y; Satoh H; Kamma H
Pathol Int; 2005 Jun; 55(6):353-9. PubMed ID: 15943793
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathologic implications of E-cadherin reactivity in patients with lobular carcinoma in situ of the breast.
Goldstein NS; Kestin LL; Vicini FA
Cancer; 2001 Aug; 92(4):738-47. PubMed ID: 11550142
[TBL] [Abstract][Full Text] [Related]
18. Signet ring lobular carcinoma in situ as a part of the "Rosen Triad" (tubular carcinoma, columnar cell hyperplasia, and lobular carcinoma in situ).
Bezic J; Gugic D
Turk Patoloji Derg; 2013; 29(2):134-7. PubMed ID: 23661351
[TBL] [Abstract][Full Text] [Related]
19. E-cadherin expression in invasive non-lobular carcinoma of the breast and its prognostic significance.
Rakha EA; Abd El Rehim D; Pinder SE; Lewis SA; Ellis IO
Histopathology; 2005 Jun; 46(6):685-93. PubMed ID: 15910600
[TBL] [Abstract][Full Text] [Related]
20. Expression of sialyl lewis X, sialyl Lewis A, E-cadherin and cathepsin-D in human breast cancer: immunohistochemical analysis in mammary carcinoma in situ, invasive carcinomas and their lymph node metastasis.
Jeschke U; Mylonas I; Shabani N; Kunert-Keil C; Schindlbeck C; Gerber B; Friese K
Anticancer Res; 2005; 25(3A):1615-22. PubMed ID: 16033070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
